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ABSTRACT 
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths worldwide. Unresectable 
HCC is currently being treated using local injections of chemo- or radioembolization particles during 
transarterial liver catheterization. This strategy aims to increase local drug concentrations near the tumorous 
tissue. Though promising, the optimal treatment conditions are still unknown. As the vasculature feeding the 
tumor plays a key role, we explored the added value of 3D numerical models to optimize HCC drug delivery. 
A patient-specific 3D hepatic arterial geometry was obtained from micro-CT data of a human liver [1] and 
meshed using 8.9 million volume elements. Computational fluid dynamics (CFD) calculations were 
performed using Fluent (Ansys, USA) to simulate both the blood flow (continuous shear-thinning fluid 
phase) and drug particle transport (discrete phase) in the liver. Particle tracking allowed calculating the 
trajectories of individual drug carriers through the 3D flow field. Baseline boundary conditions included a 
velocity inlet of 0.155 m/s at the hepatic artery, an outlet flow distribution (Murray’s law) and a uniform 
surface injection of 104 particles. A sensitivity study was performed to study the impact of relevant 
parameters (injection velocity, particle size etc.) on the particle distribution. 
Results showed that the cross-sectional injection location has a large impact on the particle distribution, as 
also found in [2]. A good choice of this parameter may allow targeting a specific outlet or tumor. Other 
parameters having a significant impact on the particle distribution, are the injection plane (proximal/distal 
catheter position), the particle density (1600-3600 kg/m³), and the particle diameter (40-100 µm), leading to 
changes in the outlet-specific number of exiting particles up to ± 64%, 61%, and 79%, respectively. In 
contrast, variations of the injection velocity (0.1-0.2 m/s) had only little impact (up to ± 6%). 
This feasibility study indicates the potential of patient-specific computational models to optimize targeted 
drug delivery for liver cancer [3]. Future work will focus on validating the numerical modelling approach 
and testing it in a cohort of HCC patients that received transarterial therapy. 
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